ALSERES PHARMACEUTICALS INC /DE company info

CIK 94784
IRS Number 870277826
State of incorporation DE
Business address 239 SOUTH STREET
None
HOPKINTON
MA
01748
Mail address 239 SOUTH STREET
None
HOPKINTON
MA
01748

Short summary

ALSERES PHARMACEUTICALS INC /DE is a Massachusetts company, with head office located at 239 South Street Hopkinton, Massachusetts 01748. In 2013 the company owned a total of 279.02 thousand USD worth of assets, including 220.04 thousand USD worth of current assets. 2010 was the year when the company amassed the most assets.

ALSERES PHARMACEUTICALS INC /DE Income Statement

Name [in Millions USD]2007200820092010201120122013Trends
Operating Expenses 3.121.571.741.04
Operating Income (Loss) -3.12-1.57-1.21-0.56
Interest expense 2.641.840.43
Investment Income, Interest and Dividend 0.000.000.000.00
Other Nonoperating Income (Expense) 0.040.000.34
Income Tax Expense (Benefit)
Net income -19.55-20.85-10.780.51-2.88-1.65-0.94

ALSERES PHARMACEUTICALS INC /DE Balance Sheet

Name [in Millions USD]2007200820092010201120122013Trends
Cash and cash equivalents 0.030.070.060.030.05
Property, Plant and Equipment, Gross 0.030.030.03
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.030.030.03
Total assets 0.340.130.150.28
Current assets 0.210.130.090.22
Total current liabilities 43.8031.009.831.81
Deferred Revenue, Noncurrent 1.181.11
Total liabilities 43.8031.0027.0411.26
Common Stock, Value, Issued 0.310.310.310.31
Retained Earnings (Accumulated Deficit) -195.78-197.37
Accumulated Other Comprehensive Income (Loss), Net of Tax 0-0.04-0.03-0.05

ALSERES PHARMACEUTICALS INC /DE Cash Flow

Name [in Millions USD]2007200820092010201120122013Trends
Net income -19.55-20.85-10.780.51-2.88-1.65-0.94
Depreciation and amortization 0.060.040.000.00
Deferred revenue 0.20-0.07
Net Cash Provided by (Used in) Operating Activities -2.95-2.48-0.95-1.69
Payments to Acquire Property, Plant, and Equipment 0.00
Net Cash Provided by (Used in) Investing Activities 0.040.300.88
Proceeds from Issuance of Common Stock
Payments for Repurchase of Common Stock 0.010.020.00
Net Cash Provided by (Used in) Financing Activities 2.702.220.830.90
Cash and Cash Equivalents, Period Increase (Decrease) -0.220.04-0.120.10